2003-11-01
Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment
Publication
Publication
European Journal of Endocrinology , Volume 149 - Issue 5 p. 443- 447
Additional Metadata | |
---|---|
doi.org/10.1530/eje.0.1490443, hdl.handle.net/1765/56033 | |
European Journal of Endocrinology | |
Organisation | Department of Internal Medicine |
Weetman, A., Shepherdley, C., Mansell, P., Ubhi, C., & Visser, T. (2003). Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment. European Journal of Endocrinology, 149(5), 443–447. doi:10.1530/eje.0.1490443 |